Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2019 Jul 1;23(7):797–804. doi: 10.5588/ijtld.18.0757

Table 2.

Demographic and Clinical Characteristics of US–Born Tuberculosis Patients by Period, US National Tuberculosis Surveillance System, 2010–2013, compared with 2014–2017.

Characteristic 2010–2013
n = 15217
No. (%)
2014–2017
n = 11859
No. (%)
Adjusted Risk Ratio (95% Confidence Interval)a P-value
Age (years)
0–4 1119 (7.4) 832 (7.0) 0.98 (0.9–1.1) .53
5–14 549 (3.6) 477 (4.0) 1.1 (1.0–1.2) .05
15–24 1334 (8.9) 1110 (9.4) 0.98 (0.9–1.0) .38
25–44 3244 (21.3) 2539 (21.4) Ref.
45–64 5545 (36.4) 4106 (34.6) 1.0 (1.0–1.1) .30
≥65 3426 (22.5) 2792 (23.5) 1.1 (1.0–1.2) <.0001
Race/Ethnicity
White, non-Hispanic 5088 (33.4) 3667 (30.9) Ref.
Asian, non-Hispanic 535 (3.5) 560 (4.7) 1.3 (1.2–1.4) <.0001
Black, non-Hispanic 5905 (38.8) 4399 (37.1) 1.0 (1.0–1.1) .29
Hispanic 2917 (19.2) 2507 (21.1) 1.1 (1.1–1.2) <.0001
American Indian/Alaskan Native, non-Hispanic 536 (3.5) 462 (3.9) 1.1 (1.0–1.2) .003
Native Hawaiian/Pacific Islander, non-Hispanic 110 (0.7) 158 (1.3) 1.5 (1.3–1.7) <.0001
Other, non-Hispanicb 126 (0.8) 106 (0.9) 1.1 (0.9–1.3) .21
HIV status (referent = HIV status negative)
Positive 1271 (8.4) 804 (6.8) 0.8 (0.8–0.9) <.0001
Unknownc 3039 (20.0) 1530 (12.9) 0.7 (0.6–0.7) <.0001
Site of disease (referent = extra-pulmonary disease)
Pulmonary disease only 11267 (74.0) 8748 (73.8) 1.0 (1.0–1.1) .036
Pulmonary and extra-pulmonary disease 1318 (8.7) 1121 (9.5) 1.1 (1.0–1.2) .005
Chest radiology (referent = normal chest radiograph)
Cavitary disease 3561 (23.4) 2719 (22.9) 0.9 (0.9–1.0) .005
No cavitary disease 8793 (57.8) 6867 (57.9) 1.0 (0.9–1.0) .08
Sputum smear results (referent = smear negative)
Positive 5585 (36.7) 4516 (38.1) 1.1 (1.0–1.1) .002
Unknown 3274 (21.5) 2573 (21.7) 1.1 (1.0–1.2) <.0001
Other Risk Factors (referent = not having risk factor)
Residing in a correctional institution 743 (4.9) 515 (4.3) 0.8 (0.7–0.9) <.0001
Excess alcohol use 3067(20.2) 2089 (17.6) 0.9 (0.8–0.9) <.0001
Noninjecting-drug use 2158 (14.2) 1846 (15.6) 1.2 (1.1–1.2) <.0001

AIDS, acquired immunodeficiency syndrome; HIV, human immunodeficiency virus.

a

Adjusted risk ratio and 99% confidence intervals shown for patient characteristics left in the final multivariable model. Variables were adjusted for sex; homelessness, injecting-drug use within the year prior to diagnosis; living in a longterm care facility at the time of diagnosis of TB; diabetes, end-stage renal disease, previous history of TB, history of incomplete treatment with tumor necrosis factor-alpha antagonist drugs, contact with an MDR TB patient, being missed contact of a person with TB disease, post-organ transplantation, immunosuppression not associated with HIV/AIDS, treatment for latent tuberculosis infection, contact with an infectious TB or a multidrug-resistant TB patient, missed contact with active TB patient.

b

“Other” race/ethnicity includes persons of unknown or missing race (2010–2013, n = 42, 2014–2017, n = 12) and more than one race selected (2010–2013, n = 84; 2014–2017, n = 94).

c

HIV, Human immunodeficiency virus status unknown is a combination of test result unknown, test refused, test not done, test not offered, and test result indeterminate.